2025 Connect in Nashville: Setting the agenda for health care's future
Eroding trust, soaring costs, accelerating AI and an exhausted workforce are testing the limits of even the most resilient organizations. This fall, the most influential voices in health care will unite to define what comes next.
At the Health Evolution Summit XV, leaders laid the groundwork for what's ahead. Dr. Mehmet Oz, administrator of the Centers for Medicare and Medicaid Services (CMS), sparked a critical conversation about leadership in health care amidst a shifting societal landscape.
He emphasized that the new administration is eager to work with industry leaders to ask difficult questions — not to assign blame for current challenges, but to reexamine the fundamental issues driving health problems. Oz called for a renewed focus on tackling root causes while offering a fresh perspective on the responsibilities of leadership in shaping the future of health care.
As the health care landscape continues to shift, the Health Evolution community is stepping up to set the agenda. With the next administration taking shape and the need for clarity and collaboration more urgent than ever, 2025 Connect will bring together the leaders driving real progress — defining priorities, informing policy and shaping a system built to serve.
expand
WILDE COMPANY PHOTO
Experience 2025 Connect in Nashville
Join Health Evolution from Sept. 7-10 at the JW Marriott in Nashville for 2025 Connect. This event offers a unique opportunity to immerse yourself in the collaborative energy of our unmatched community of executive leaders and engage in authentic, off-the-record discussions that drive industry transformation.
At 2025 Connect, you'll be at the heart of cross-sector conversations with industry leaders, innovators and stakeholders. Our agenda fosters genuine interactions and collaborative problem-solving, providing an in-depth look at the challenges and opportunities shaping the future of health care.
What to expect at 2025 Connect
Over four days, you'll engage in dynamic discussions on the critical issues reshaping health care. You'll engage with thought leaders on deploying AI to address health care's toughest challenges, advancing equitable innovation, scaling effective care models, navigating policy change and more.
Our conversations will go beyond the headlines to explore the underlying factors driving change. You'll gain insights on overcoming industry challenges, driving innovation and discovering transformative strategies. This is your opportunity to delve deep into the factors that will define the future of health care.
expand
WILDE COMPANY PHOTO
At 2025 Connect, you'll have the opportunity to hear from and collaborate with health care's leading experts and decision-makers. Here's a glimpse of the topics our leaders will be tackling on the main stage:
Crisis in confidence: Reckoning with consumer pain points, public sentiments, and loss of trust
Reckoning with consumer pain points, public sentiments, and loss of trust Reengineering the consumer experience: Confronting the friction that fuels frustration
Confronting the friction that fuels frustration Navigating the new policy landscape: Deciphering the latest developments and charting the course ahead
Deciphering the latest developments and charting the course ahead Leading despite uncertainty: Finding untapped opportunities and inspiring bold action
Finding untapped opportunities and inspiring bold action Putting AI to work: Deploying technology against our hardest challenges
Deploying technology against our hardest challenges Delivering better care: Scaling effective models for treating chronic disease and an aging population
Scaling effective models for treating chronic disease and an aging population Unlocking the full promise of personalization: Empowering longitudinal health and wellness
Empowering longitudinal health and wellness Community milestone: Celebrating the 10th confab for advancing women in leadership
Unlock your role among the brightest minds in health care
Health Evolution Connect is your opportunity to be at the forefront of health care innovation. Engage in collaborative discussions, explore groundbreaking solutions and gain insights that will drive the future of the industry.
Be part of a community that is not just observing change but actively driving it. Connect with top experts, uncover cutting-edge strategies, and redefine the future of health care. This event provides a dynamic environment where you can influence the industry agenda and explore pioneering solutions to today's most pressing challenges.
Secure your spot today.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Axios
20 hours ago
- Axios
Traditional Medicare to add prior authorizations
Medicare is requiring more pre-treatment approvals in its fee-for-service program in a bid to root out unnecessary care, federal regulators announced Friday. The big picture: Traditional Medicare historically hasn't required prior authorizations to access most drugs or services, a major perk for enrollees. Prior authorization in privately-run Medicare Advantage plans has become a hot-button issue, with Congress and federal regulators working to rein in the practice. Federal inspectors found in 2022 that prior authorization in MA prevented some seniors from getting medically necessary care. Major health insurers this week made a voluntary pledge to streamline and improve the prior authorization process across all health insurance markets. State of play: Medicare's innovation center announced that it will solicit applications from companies to run the prior authorization program. Medicare is looking for companies with experience using AI and other tools to manage pre-approvals for other payers, and with clinicians who can conduct medical reviews to check coverage determinations. The program will start Jan. 1, 2026 and run through the end of 2031. It will only apply to providers and patients in New Jersey, Ohio, Oklahoma, Texas, Arizona and Washington. The change will apply to 17 items and services, including skin substitutes, deep brain stimulation for Parkinson's Disease, impotence treatment and arthroscopy for knee osteoarthritis. CMS selected the services based on previous reports and evidence of fraud, waste and abuse, as well as what's already subject to prior authorization in Medicare Advantage. Overuse of skin substitutes to help heal wounds has especially come under fire in recent years. Medicare spent more than $10 billion on the products in 2024 — more than double what was spent the year before, according to the New York Times. CMS noted that it may make other services subject to the prior authorization program in future years. Providers in the geographic areas can choose whether or not they want to submit an authorization request before delivering a service. But if they decide not to, they'll be subject to post-claim review and risk not getting paid for a service that was already delivered. "In general, this model will require the same information and clinical documentation that is already required to support Medicare FFS payment but earlier in the process, namely, prior to the service being furnished," the notice reads. Zoom in: The companies hired to manage the program will be paid based on how much they saved the government by stopping payments for unnecessary services. "Under the model, we will work to avoid any adverse impact on beneficiaries or providers/suppliers," CMS wrote in the notice.
Health Line
a day ago
- Health Line
How much does Farxiga cost with Medicare?
Farxiga can cost up to $600 without insurance, with costs varying by pharmacy and whether you choose the brand or the generic. With Medicare coverage, your out-of-pocket costs depend on your plan. Farxiga (dapagliflozin) is a medication for helping lower blood sugar levels and reduce the risk of heart and kidney issues for those with type 2 diabetes, heart failure, or chronic kidney disease. With Medicare, drug overage usually comes through a Medicare Part D or a Medicare Advantage Prescription Drug (MAPD) plan. But whether your plan covers Farxiga and how much the drug will cost after coverage depends on your plan. How much does Farxiga cost per month with Medicare? Depending on where you get it, the cost of Farxiga without insurance can be over $600. The generic version, dapagliflozin, still costs more than $400. Farxiga can be covered by Medicare Part D or a MAPD plan. However, whether this medication or its generic version is covered by your Medicare drug plan and how much the plan will cover depends on its specific list of covered drugs, called a formulary. Private insurers manage Medicare drug plans and will have a different list depending on the plan. In addition, keep in mind that Medicare drug plans also have a deductible, premium, and copay that can vary depending on the plan. In 2025, the national base beneficiary premium for Part D is $36.78. According to the Centers for Medicare & Medicaid Services (CMS), the average monthly premium for Medicare Advantage plans is $17. What tier is Farxiga on? Within your plan's formulary, the insurer will place Farxiga in a tier. Generally, the higher the tier, the more you'll pay as a copayment, with the generic version typically in a lower tier than the brand-name drug. Many Medicare drug plans should include Farxiga, though its tier will depend on your plan. If your plan doesn't include this drug, it may include an alternative and equally effective medication. Generally, Medicare drug plans must cover at least two drugs from the most commonly prescribed categories. If the plan includes it and classifies it in a higher tier, your insurer may require prior authorization for coverage, which could include Step Therapy. This means you'll be asked to try a different, equally effective, but more cost-effective medication first before Medicare will approve coverage for Farxiga. Takeaway Farxiga is a drug designed to help lower blood sugar levels and reduce the risk of heart and kidney issues for those with type 2 diabetes, heart failure, or chronic kidney disease. Without insurance, the cost of Farxiga can range from around $400 to $600, depending on the pharmacy and whether you choose the brand-name or generic version. Usually, Medicare drug coverage comes through a Medicare Part D plan. While your exact coverage and costs for Farxiga depend on the specifics of your plan, many Medicare plans should cover this medication. Plus, once Medicare's price negotiation agreement starts in 2026, the price with coverage should be more affordable. The information on this website may assist you in making personal decisions about insurance, but it is not intended to provide advice regarding the purchase or use of any insurance or insurance products. Healthline Media does not transact the business of insurance in any manner and is not licensed as an insurance company or producer in any U.S. jurisdiction. Healthline Media does not recommend or endorse any third parties that may transact the business of insurance.
Yahoo
a day ago
- Yahoo
HealthLynked partners with Endlink to enhance hospital connectivity
HealthLynked has entered into a strategic collaboration with data integration firm Endlink for improving connectivity between hospital systems and electronic medical records (EMRs). This connectivity is expected to facilitate coordinated patient care. Endlink co-founder and chief technology officer Rubén Viera brings expertise in healthcare IT standards such as FHIR, HL7, and CMS to the partnership. HealthLynked CEO Michael Dent said: 'Rubén's leadership in healthcare IT and his deep understanding of both clinical and operational workflows make him an exceptional partner as we expand HealthLynked's capabilities. 'This partnership represents a powerful synergy between our shared vision of connected, patient-centred care and Endlink's proven solutions already transforming hospitals in Puerto Rico.' Endlink's platform, which backs more than 300,000 members across Puerto Rico, has played a pivotal role in streamlining processes for two of the territory's hospital networks. The integration of lab findings, alerts, and patient information into instantaneous, mobile-compatible procedures has resulted in swifter specialist response times, thereby elevating the standard of patient care and clinical results. Viera said: 'We believe that the future of healthcare depends on transforming data into action. 'At Endlink, we've always focused on empowering healthcare organisations to unlock the full potential of their data. Partnering with HealthLynked allows us to take this further—by delivering even more intelligent, integrated, and patient-focused solutions.' The partnership will see the integration of HealthLynked's suite of tools, including virtual care access, secure patient records and AI-powered insights, into the current hospital and payer client base of Endlink. HealthLynked will be able to further its reach into data-driven care management and hospital system innovation. It underscores HealthLynked's aim to make healthcare more connected, personalised, and accessible. "HealthLynked partners with Endlink to enhance hospital connectivity" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
